In addition to leading research on GLP-1, Professor Habener also played a central role in clinical trials and the commercialization process of drugs based on GLP-1, opening new opportunities for hundreds of millions of diabetes and obesity patients worldwide
If you are ready to start a journey that is medically supervised and tailored to your unique needs, we invite you to take the free assessment quiz toward a healthier you
Second, positioning L-carnitine as a metabolic re-sensitizer to evaluate its potential, alone or combined with SGLT2 inhibitors, in restoring hepatic insulin sensitivity among type 2 diabetes patients with MASLD who respond poorly to or cannot tolerate metformin
Are Certain Types of Sugars Healthier Than Others
Beyond its role in diabetes management, liraglutide has proven effective in treating obesity, even among non-diabetic individuals
Many users searching for semaglutide weight loss solutions often compare it with intermittent fasting (IF) to determine which approach delivers faster results, better sustainability, and long-term success
